Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

12/12/2008 Telecon - RiaSTAP


From:Laura Wood, OBRR/DH/LH
To: The file of STN 125317/0 and Vasantha Kumar, OBRR/DBA/RPMB
Company:CSL Behring GmbH
Product:Fibrinogen Concentrate (Human), RiaSTAP™
Subject:Telephone call with David Desris


 On December 12, 2008, Mr. Desris called to see when the company would be receiving a communication from CBER regarding the pharmacovigilance and labeling reviews. I told him that we hoped to send something by the end of that week

Page Last Updated: 06/02/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English